Switching to High-Dose Aflibercept (8 mg) with Pro Re Nata Reduces Treatment Burden in Diabetic Macular Edema: A Real-World Pilot Study. [PDF]
Funatsu M +10 more
europepmc +1 more source
Terence Fullerton,1 Glenn Pixton2 1Internal Medicine and Infectious Disease, Pfizer Research and Development, Pfizer Inc., Groton, CT, USA; 2Statistics, Pfizer Inc., Groton, CT, USACorrespondence: Terence Fullerton, Internal Medicine and Infectious ...
Fullerton T, Pixton G
doaj
Evolution of Anti-Vascular Endothelial Growth Factor Clinical Trial Design for Treating Neovascular Age-Related Macular Degeneration. [PDF]
Klufas MA +3 more
europepmc +1 more source
Non-Opioid Pharmaceutical Alternatives for Acute Pain Management in the Emergency Department: A Scoping Review. [PDF]
Shanmugam A +5 more
europepmc +1 more source
Trends and Outcomes of Naloxone Use for Iatrogenic Opioid Overdose in Patients on General Wards in a Swiss Hospital: A Ten-Year Retrospective Case Series Analysis. [PDF]
Würsten M +3 more
europepmc +1 more source
Correction: Healing spaces: a retrospective cohort study on the effect of outdoor spaces in psychiatric inpatient units on PRN medication use, seclusion/restraints, and constant observation. [PDF]
Liu K, Saito E, Linder H.
europepmc +1 more source
Prevalence and Predictors of Chronic Postsurgical Pain After Primary Pediatric Scoliosis Surgery: A Tertiary Hospital Study. [PDF]
Muawad R +6 more
europepmc +1 more source
Pharmacotherapy for pediatric and adolescent agitation in an inpatient behavioral health unit. [PDF]
Yang M, Rarrick CM, Ross C.
europepmc +1 more source
Use of Aflibercept 8 mg for the Treatment of Diabetic Macular Edema in Italy: A Cost-Minimisation Analysis Based on an Indirect Treatment Comparison. [PDF]
Cortesi PA +6 more
europepmc +1 more source
Serial aqueous VEGF analysis for predicting anti-VEGF treatment outcomes in neovascular glaucoma from diabetic retinopathy: a prospective analysis. [PDF]
Joo T, Joo JH.
europepmc +1 more source

